Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Zhangjiang Park and CRO Sundia MediTech Form Incubator

publication date: Feb 11, 2009

Shanghai Zhangjiang (Group) Co., which operates the Zhangjiang Hi-Tech Park, has joined with CRO Sundia MediTech Company (桑迪亚医药技术(上海)有限公司) to expand the concept of a CRO. The two companies have formed a platform that combines Intellectual Property, CRO and Venture Capital services in one group, a biopharma incubator that includes its own CRO. The goal is take a young biopharma from original discovery into clinical trials. At the same time, the incubator will help draw the best young biopharmas to Zhangjiang Park. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital